These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25973542)

  • 1. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
    Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
    Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.
    Liu Y; Zhang N; Wang Y; Xu M; Liu N; Pang X; Cao J; Ma N; Pang H; Liu L; Zhang H
    Cancer Sci; 2012 Aug; 103(8):1420-8. PubMed ID: 22632166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
    PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
    Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
    Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.
    Sundararajan V; Gengenbacher N; Stemmler MP; Kleemann JA; Brabletz T; Brabletz S
    Oncotarget; 2015 Sep; 6(29):27083-96. PubMed ID: 26334100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1.
    Zhou W; Thiery JP
    J Cell Sci; 2013 Jun; 126(Pt 12):2740-6. PubMed ID: 23591815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
    Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
    Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
    Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
    Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.
    Asakura T; Yamaguchi N; Ohkawa K; Yoshida K
    Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
    Wu HT; Zhong HT; Li GW; Shen JX; Ye QQ; Zhang ML; Liu J
    J Transl Med; 2020 Feb; 18(1):51. PubMed ID: 32014049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.